CO2023014571A2 - Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad - Google Patents
Recubrimiento protector para composiciones farmacéuticas sensibles a la humedadInfo
- Publication number
- CO2023014571A2 CO2023014571A2 CONC2023/0014571A CO2023014571A CO2023014571A2 CO 2023014571 A2 CO2023014571 A2 CO 2023014571A2 CO 2023014571 A CO2023014571 A CO 2023014571A CO 2023014571 A2 CO2023014571 A2 CO 2023014571A2
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutical compositions
- protective coating
- moisture sensitive
- sensitive pharmaceutical
- wax
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000011253 protective coating Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Paints Or Removers (AREA)
Abstract
Se proporcionan composiciones farmacéuticas y métodos para preparar composiciones farmacéuticas que comprenden tabletas recubiertas con cera. Específicamente, se puede aplicar un recubrimiento de cera a una tableta farmacéutica antes del proceso de recubrimiento de película.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163197880P | 2021-06-07 | 2021-06-07 | |
PCT/US2022/072742 WO2022261610A1 (en) | 2021-06-07 | 2022-06-03 | Protective coating for moisture sensitive pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2023014571A2 true CO2023014571A2 (es) | 2023-11-10 |
Family
ID=82482845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2023/0014571A CO2023014571A2 (es) | 2021-06-07 | 2023-10-26 | Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP4351526A1 (es) |
JP (1) | JP2024520160A (es) |
KR (1) | KR20240019293A (es) |
CN (1) | CN117440800A (es) |
AU (1) | AU2022289906A1 (es) |
BR (1) | BR112023022209A2 (es) |
CA (1) | CA3219239A1 (es) |
CO (1) | CO2023014571A2 (es) |
IL (1) | IL308749A (es) |
MX (1) | MX2023012915A (es) |
WO (1) | WO2022261610A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ501248A (en) * | 1997-08-26 | 2001-06-29 | Aventis Pharma Inc | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
US20080096979A1 (en) * | 2004-11-08 | 2008-04-24 | Rubicon Research Pvt. Ltd. | Aqueous Pharmaceutical Coating |
CN104470371A (zh) * | 2012-07-18 | 2015-03-25 | 丹尼斯科美国公司 | 熔化延迟的颗粒 |
JP2023502389A (ja) * | 2019-11-21 | 2023-01-24 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | ウィルソン病患者における神経損傷を低下させるための方法 |
-
2022
- 2022-06-03 KR KR1020247000714A patent/KR20240019293A/ko unknown
- 2022-06-03 IL IL308749A patent/IL308749A/en unknown
- 2022-06-03 JP JP2023574831A patent/JP2024520160A/ja active Pending
- 2022-06-03 CA CA3219239A patent/CA3219239A1/en active Pending
- 2022-06-03 WO PCT/US2022/072742 patent/WO2022261610A1/en active Application Filing
- 2022-06-03 EP EP22740729.3A patent/EP4351526A1/en active Pending
- 2022-06-03 BR BR112023022209A patent/BR112023022209A2/pt unknown
- 2022-06-03 MX MX2023012915A patent/MX2023012915A/es unknown
- 2022-06-03 AU AU2022289906A patent/AU2022289906A1/en active Pending
- 2022-06-03 CN CN202280040615.XA patent/CN117440800A/zh active Pending
-
2023
- 2023-10-26 CO CONC2023/0014571A patent/CO2023014571A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112023022209A2 (pt) | 2024-02-06 |
KR20240019293A (ko) | 2024-02-14 |
CN117440800A (zh) | 2024-01-23 |
CA3219239A1 (en) | 2022-12-15 |
WO2022261610A1 (en) | 2022-12-15 |
AU2022289906A1 (en) | 2023-11-09 |
EP4351526A1 (en) | 2024-04-17 |
JP2024520160A (ja) | 2024-05-21 |
IL308749A (en) | 2024-01-01 |
MX2023012915A (es) | 2024-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
CO2019007839A2 (es) | Composiciones y métodos para inhibir la acción de la arginasa | |
UY37732A (es) | Complemento para piensos | |
PE20200478A1 (es) | Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion | |
BR112017000730B8 (pt) | Derivados de pirrolidinona como inibidores de metap-2, e medicamentos | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
BR112017013598A2 (pt) | composições de revestimento de película entérico, método de revestimento, e formas revestidas | |
EP3741687A4 (en) | INDIVIDUAL PACKAGING DEVICE FOR TABLETS | |
CL2016002678A1 (es) | “compuestos derivados de heteroarilo, ligantes d1; composición farmacéutica que los comprende; útiles en el tratamiento de enfermedades del snc, autoinmune, metabólicas, entre otras”. pct | |
ES2930589R1 (es) | Envase que contiene cápsulas hidrosolubles | |
CO2023014571A2 (es) | Recubrimiento protector para composiciones farmacéuticas sensibles a la humedad | |
CO2019000604A2 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d | |
UY35750A (es) | Moduladores octahidro-ciclopenta[c] pirrol negativos de nr2b | |
TWD191369S (zh) | 產品包裝之部分 | |
MX2017006561A (es) | Formulaciones farmaceuticas de matriz comprenden dimetilfumarato. | |
AR110134A1 (es) | Pastilla liberación no abrupta de una dosis inducida por alcohol basado en alcohol polivinílico | |
EP3874954A4 (en) | SOLID COMPOSITION FOR PLANT CARE WITH FUNGI SCLEROTIUM AND ITS USE | |
UA113442C2 (xx) | Ентеросорбент | |
EA201991288A1 (ru) | Фармацевтические композиции на основе дабигатрана | |
TR201722102A2 (tr) | Levodropropizin İçeren Farmasötik Bir Ürün | |
AR103253A1 (es) | Composición de compuestos de salicilato | |
CR20150411A (es) | Composiciones farmacéuticas que contienen dexketoprofeno y tramadol | |
AR100820A1 (es) | Formulaciones de comprimido bi-capa de ciclofosfamida y capecitabina y administración metronómica altamente fraccionada de las mismas | |
UA120295U (uk) | Лікарській засіб антитромбоцитарної дії | |
TR201714736A2 (tr) | Kabuklu kuruyemi̇ş ambalajlari i̇çi̇n seperatör |